Expression of FOXA1 and EZH2 in Breast Cancer and Association with Clinicopathological Features and TP53/RB1 Alterations

被引：0
|
作者：
Shi, Mingxia [1 ]
Yang, Shu [2 ]
Shi, Runhua [2 ]
Cheng, Siyuan [3 ]
Lopez, Liurka [3 ]
Yu, Xiuping [2 ]
机构：
[1] Univ S Alabama, Coll Med, Mobile, AL USA
[2] LSU Hlth Shreveport, Shreveport, LA USA
[3] LSU Hlth Sci Ctr Shreveport, Shreveport, LA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
263
引用
收藏
页码：260 / 260
页数：1
相关论文
共 50 条
  • [1] Expression of FOXA1 and EZH2 in Breast Cancer and Association with Clinicopathological Features and TP53/RB1 Alterations
    Shi, Mingxia
    Yang, Shu
    Shi, Runhua
    Cheng, Siyuan
    Lopez, Liurka
    Yu, Xiuping
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 260 - 260
  • [2] Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer
    Xu, Xiaofei
    Xie, Limei
    Meng, Liwei
    Geng, Shangzhen
    Liu, Jin
    Cao, Xiangting
    Dong, Zhaogang
    Xing, Zhaoquan
    [J]. BIOSCIENCE TRENDS, 2022, 16 (03) : 221 - 229
  • [3] FOXA1 expression: regulated by EZH2 and associated with favorable outcome to tamoxifen in advanced breast cancer
    Reijm, E. A.
    Helmijr, J. C. A.
    Soler, C. M. J.
    Beekman, R.
    Gerritse, F. L.
    Prager-van der Smissen, W. J. C.
    Ruigrok-Ritstier, K.
    van IJcken, W. F. J.
    Stevens, M. G.
    Smid, M.
    Look, M. P.
    Meijer, M. E.
    Sieuwerts, A. M.
    Sleijfer, S.
    Foekens, J. A.
    Berns, E. M. J. J.
    Jansen, M. P. H. M.
    [J]. CANCER RESEARCH, 2012, 72
  • [4] EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
    Pietersen, Alexandra M.
    Horlings, Hugo M.
    Hauptmann, Michael
    Langerod, Anita
    Ajouaou, Abderrahim
    Cornelissen-Steijger, Paulien
    Wessels, Lodewijk F.
    Jonkers, Jos
    van de Vijver, Marc J.
    van Lohuizen, Maarten
    [J]. BREAST CANCER RESEARCH, 2008, 10 (06)
  • [5] EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
    Alexandra M Pietersen
    Hugo M Horlings
    Michael Hauptmann
    Anita Langerød
    Abderrahim Ajouaou
    Paulien Cornelissen-Steijger
    Lodewijk F Wessels
    Jos Jonkers
    Marc J van de Vijver
    Maarten van Lohuizen
    [J]. Breast Cancer Research, 10
  • [6] Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells
    Forma, Ewa
    Jozwiak, Pawel
    Ciesielski, Piotr
    Zaczek, Agnieszka
    Starska, Katarzyna
    Brys, Magdalena
    Krzeslak, Anna
    [J]. PLOS ONE, 2018, 13 (06):
  • [7] TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer
    Mu, Ping
    Cao, Zhen
    Hoover, Elizabeth
    Wongvipat, John
    Huang, Chun-Hao
    Karthaus, Wouter
    Abida, Wassim
    De Stanchina, Elise
    Sawyers, Charles
    [J]. CANCER RESEARCH, 2015, 75
  • [8] Expression of BCL2, TP53, FOXA1, and GATA3 in pTa bladder cancer recurrence
    Novakova, Zuzana Varchulova
    Harsanyi, Stefan
    Bevizova, Katarina
    Kuniakova, Marcela
    Schwarzova, Lucia
    Trebaticky, Branislav
    Danisovic, Lubos
    Ziaran, Stanislav
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (05): : 311 - 317
  • [9] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
    Li, Xuerui
    Chen, Xiaoqing
    Wen, Lingzhu
    Wang, Yulei
    Chen, Bo
    Xue, Yunlian
    Guo, Liping
    Liao, Ning
    [J]. THORACIC CANCER, 2020, 11 (07) : 1861 - 1868
  • [10] RB1 AND TP53 LOSS PROMOTES LINEAGE PLASTICITY IN PROSTATE CANCER
    不详
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 244 - 244
12345